Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Surabaya
92%
Chronic Kidney Disease
77%
Cervical Cancer
69%
Indonesia
65%
Disease-free Survival
51%
COVID-19
46%
Cervical Cancer Patients
40%
Chronic Kidney Disease Patients
40%
Chemotherapy
37%
Cardiovascular Mortality Risk
37%
Indonesian
33%
Ovarian Cancer
33%
Clinical Characteristics
31%
Cardiovascular Mortality
31%
Overall Survival
29%
Cervical Cancer Prevention
28%
Tertiary Hospital
27%
Vaginal Laxity
27%
General Hospital
25%
Mortality Prediction
24%
Atherosclerotic Cardiovascular Disease (ASCVD)
23%
Systematic Meta-analysis
23%
Meta-analysis
23%
Gynecological Cancer
22%
Risk Factors
21%
Epithelial Ovarian Cancer
21%
Obstetrics and Gynaecology
21%
Medical Records
21%
Retrospective Cohort Study
21%
Fractional Laser
21%
Human Papillomavirus Vaccine
20%
Prognostic Factors
19%
Confidence Interval
19%
Disease Progression
18%
Indonesian Women
18%
Referral Hospital
18%
8-hydroxydeoxyguanosine (8-OHdG)
18%
Carotid-femoral Pulse Wave Velocity (cfPWV)
18%
Antihypertensive Drugs
18%
Critically Ill COVID-19 Patients
18%
High-risk Endometrial Cancer
18%
Heat Shock Factor 1 (HSF1)
18%
Insulin Resistance
18%
Elderly Patients
18%
Angiotensin-converting Enzyme
18%
Interleukin-6 Levels
18%
Sarcopenia
18%
Non-dialysis Chronic Kidney Disease
18%
Abdominal Hysterectomy
18%
Menstrual Blood
18%
Cervical Swabs
18%
Gene Polymorphism
18%
Cervical Cancer Screening
18%
Mortality Rate
17%
Rattus Norvegicus
16%
Statistical Analysis
16%
Hazard Ratio
16%
CA-125 Levels
16%
High-grade Serous Epithelial Ovarian Cancer
15%
Older Women
15%
Quality of Life
14%
Cancer Treatment
14%
No Significant Difference
14%
Vaginal Delivery
14%
Early Detection
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Yttrium Aluminum Garnet
14%
Length of Stay
14%
Hypertensive
14%
High-grade Serous Ovarian Cancer (HGSOC)
14%
Single nucleotide Polymorphism
13%
Atherosclerotic Cardiovascular Disease Risk Score
13%
Radiotherapy
13%
Hypertension
13%
Gynecologist
13%
Gynecologic Oncology
12%
Neutrophil-to-lymphocyte Ratio
12%
Clinical Outcomes
12%
Neoadjuvant Chemotherapy
12%
Young Female
12%
Malignant Ovarian Tumor
12%
Chronic Kidney Disease Stage
12%
Endometrial Cancer
12%
Beta-blockers
11%
Tumor Patients
11%
Vaginal Bleeding
11%
5-year Survival
11%
Arterial Stiffness
11%
Polymorphism
11%
Universitas
11%
Hemodialysis Patients
11%
Malignancy
11%
Hysterectomy
10%
Previous Cesarean Section
10%
Screening Method
10%
Female Gynecologists
10%
Adhesion
10%
Estimated Glomerular Filtration Rate
10%
Gynecologic Oncologist
10%
Vascular Endothelial Growth Factor
10%
Medicine and Dentistry
Cervical Cancer
100%
Chronic Kidney Disease
59%
COVID-19
56%
Disease Free Survival
54%
Female Genital Tract Cancer
46%
Malignant Neoplasm
45%
Wart Virus
40%
Ovarian Cancer
40%
Krukenberg Tumor
39%
Diseases
38%
Systematic Review
37%
Neoplasm
36%
Overall Survival
29%
Erbium
28%
Pelvis
27%
Ovarian Tumor
26%
Meta-Analysis
25%
Cervical Cancer Screening
25%
Oncologist
24%
Recurrent Disease
24%
Cervix
23%
Gynecology
23%
Wart Virus Vaccine
23%
Cesarean Section
23%
Obstetrics
22%
Oncology
22%
Hysterectomy
21%
Cervical Cancer Prevention
20%
Gynecological Oncology
20%
Infection
20%
Hemodialysis
20%
Abdominal Hysterectomy
19%
Prognostic Factor
19%
Cross Sectional Study
19%
Uterine Cancer
18%
Sarcopenia
18%
Insulin Resistance
18%
Elderly Patient
18%
Cardiovascular Mortality
18%
DNA Polymorphism
18%
Radiation Therapy
18%
Neuroendocrine Carcinoma
18%
Granulosa Cell Tumour
18%
Medical Record
17%
Cancer
15%
Hazard Ratio
15%
Screening
15%
Side Effect
15%
Retrospective Study
15%
CA-125
14%
Cardiovascular Disease
14%
Observational Study
14%
Radical Hysterectomy
14%
Retroperitoneal Lymph Node Dissection
14%
DNA Screening
14%
Vaginal Delivery
13%
Acetic Acid
12%
Neoadjuvant Chemotherapy
12%
Sensitivity and Specificity
12%
Cancer Therapy
12%
Vagina Bleeding
11%
Cohort Analysis
11%
Quality of Life
11%
Adenocarcinoma
11%
Papanicolaou Stain
11%
Lymphocyte
11%
Neutrophil
11%
Patient Referral
10%
Paclitaxel
10%
Bleeding
10%
Human Development
10%
Histopathology
10%
Receptor
10%
Cancer Staging
9%
Endometrium Carcinoma
9%
Ascites
9%
Uterine Myomectomy
9%
Incision
9%
Somatic Mutation
9%
BRCA1
9%
Peritoneum Adhesion
9%
BRCA2
9%
Intrauterine Device
9%
Neurogenic Bladder
9%
Vesicoureteral Reflux
9%
Peritoneal Fibrosis
9%
Mismatch Repair Protein
9%
Protein Deficiency
9%
Beta Thalassemia
9%
Iron Overload
9%
Maternal Death
9%
Uterine Fibroid
9%
Vaginal Wall
9%
Kidney Graft
9%
Heat Shock Transcription Factor 1
9%
Laparotomy
9%
Fibrinogen
9%
Symptomatic Treatment
9%
Analgesia
9%
Cancer Diagnosis
9%